Antibodies! – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Antibodies!

The Antibody Society

Science

Frequency: 1 episode/68d. Total Eps: 3

The official podcast of The Antibody Society.

We bring you conversations with scientists and innovators working in antibody research. Each episode explores the discoveries, collaborations, and breakthroughs in antibody engineering and therapeutic development. Hosted by Jonathan Davis of Creative Antibodies, with new episodes every month.

Read moreCollapse

Site

RSS

Apple

Data updated on 14/07/2026

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://tabs-antibodiespodcast.podbean.com/
4 shares

https://www.linkedin.com/in/jonathandavis-bispecifics/
2 shares
https://www.linkedin.com/in/johndesjarlais/
1 share
https://nl.linkedin.com/in/janine-schuurman-8105a35
1 share

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

Good

Score global : 73%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Antibodies! Ep. 3: Live from Antibody Engineering & Therapeutics, San Diego, USA

Season 1 · Episode 3

Friday, June 5, 2026 • Duration 42:28

Recorded live at Antibody Engineering & Therapeutics in San Diego, Episode 3 of Antibodies! brings together leading voices from across the antibody discovery and development community for a series of conversations on some of the field’s most important challenges and opportunities.

Hosted by Jonathan Davis, PhD, Founder of Creative Antibodies, this special conference edition features discussions on target discovery, tumor specificity, bispecific and trispecific antibodies, intracellular targets, antibody developability, Fc effector functions, nanobody discovery, and the growing role of artificial intelligence in antibody research.

Featured guests include:

Katherine Harris, PhD, Chief Development, Rondo Therapeutics; President, The Antibody Society
Bryan Glaser, PhD, Senior Vice President of Business Development Invenra
Bassil Dahiyat, PhD, President & Chief Executive Officer, Director, Xencor
Jay M. Bhatt, Principal Scientist, Johnson & Johnson Innovative Medicine
Shashi Jatiani, PhD, Director of Strategic Partnerships, SeromYx Systems
Brandon DeKosky, PhD Associate Professor at MIT and The Ragon Institute/MGH
Chris Szent Gyorgyi, PhD

From emerging antibody formats and next generation targeting strategies to AI enabled discovery and developability assessment, this episode offers a snapshot of the ideas shaping the future of antibody therapeutics.

Read moreCollapse

Antibodies! Ep. 2: Fc Engineering & Bispecifics with John Desjarlais

Season 1 · Episode 2

Thursday, January 22, 2026 • Duration 36:19

We’re excited to share episode 2 of the Antibodies! podcast, recorded live at the Antibody Engineering & Therapeutics conference in San Diego.

Host ⁠Dr. Jonathan Davis⁠ PhD (Founder, Creative Antibodies) sits down with ⁠John Desjarlais⁠ PhD, Chief Scientific Officer at Xencor, to discuss learnings from two decades of antibody engineering: Fc platforms, T-cell engagers in solid tumors, and bispecifics in autoimmune disease.

In this conversation, they discuss:

How a classical trombonist ended up engineering some of the most widely used Fc platforms in antibody therapeutics
The KLH study that proved obexelimab could shut down B cells. Data so meaningful, John still keeps the plot on his office wall
Why target selectivity matters more than immune environment for T-cell engagers in solid tumors
The autoimmune gold rush: using T-cell engaging bispecifics to reset the immune system, inspired by Georg Schett’s CAR-T breakthrough
Trispecifics, AND-gate targeting, and where bispecifics can go beyond oncology

Be sure to listen all the way to the end for a surprise treat - an improvised harmonica blues duet between Jonathan and John!

If you missed our previous episodes, you can find them here: ⁠https://tabs-antibodiespodcast.podbean.com/⁠

Read moreCollapse

Antibodies! Ep. 1: The Antibody Frontier with Dr. Janine Schuurman

Season 1 · Episode 1

Monday, January 19, 2026 • Duration 45:33

Antibodies! Ep. 1: The Antibody Frontier with Dr. Janine Schuurman

For our debut episode, host ⁠Dr. Jonathan Davis⁠ (Founder, Creative Antibodies) sits down with ⁠Dr. Janine Schuurman⁠ (Board member and current President of The Antibody Society & Founder, Lust for Life Science B.V., formerly SVP Antibody Research & Technology of Genmab) to discuss collaboration, curiosity, and the future of antibody therapeutics.

In this conversation, they reflect on their professional journeys and discuss:

The mission of The Antibody Society.
The power of community and collaboration.
How unexpected results can lead to meaningful discoveries.
The joy and importance of creativity, curiosity, and experimentation.
How camaraderie sustains the antibody scientific community.

We sincerely hope you will enjoy this episode and stay with us for more conversations to come!

If you missed our previous episodes, you can find them here: ⁠https://tabs-antibodiespodcast.podbean.com/⁠

Read moreCollapse

Antibodies! – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Antibodies! – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other1

LinkedIn3

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Other1

LinkedIn3

Apple Podcasts

Spotify